S3 Ventures
S3 Ventures is a venture capital and private equity firm based in Austin, Texas, with an additional office in Houston. Founded in 2007, the firm specializes in investing in early-stage to growth-stage companies, focusing on Series A, B, and C funding rounds. S3 Ventures primarily targets sectors such as information technology, medical devices, enterprise software, SaaS, marketing, and financial services. The firm typically invests between $10 million and $20 million per equity transaction, with a geographical focus on the Southwestern United States, particularly Texas and Austin. S3 Ventures aims to exit its investments through acquisitions or initial public offerings, providing patient capital and substantial resources to empower entrepreneurs in building impactful companies.
Ictero Medical is a medical devices company focused on developing innovative solutions for patients with gallstone disease. The company has created a minimally invasive gallbladder ablation tool that allows for the treatment of high-risk patients without the need for surgical removal of the gallbladder. This device can be utilized in interventional radiology suites and requires only minimal local anesthesia, thereby reducing the associated risks of traditional surgery. By offering a definitive treatment option, Ictero Medical aims to improve patient outcomes while minimizing complications related to gallbladder surgery.
Ictero Medical is a medical devices company focused on developing innovative solutions for patients with gallstone disease. The company has created a minimally invasive gallbladder ablation tool that allows for the treatment of high-risk patients without the need for surgical removal of the gallbladder. This device can be utilized in interventional radiology suites and requires only minimal local anesthesia, thereby reducing the associated risks of traditional surgery. By offering a definitive treatment option, Ictero Medical aims to improve patient outcomes while minimizing complications related to gallbladder surgery.
BrainCheck, Inc. specializes in cognitive health solutions aimed at healthcare and athletic organizations in the United States. Founded in 2013 and based in Houston, Texas, the company offers BrainCheck, a mobile interactive screening tool available on iOS and Android devices. This tool enables users to monitor their cognitive health, particularly concerning issues like concussions and memory changes, by tracking performance over time and comparing results with general population data. The development of BrainCheck is grounded in two decades of research from the Eagleman Laboratory for Perception and Action at Baylor College of Medicine, led by Dr. David Eagleman. The platform encourages users to engage in meaningful discussions with their clinicians regarding their cognitive health, thereby facilitating informed decision-making. Through its innovative approach, BrainCheck aims to enhance understanding of brain function and empower individuals with actionable data.
Buildforce is a developer of a construction labor platform aimed at improving project outcomes in the construction industry. The company offers a labor marketplace that connects skilled tradesmen with construction firms, alongside workforce management and payroll software-as-a-service. This platform enables clients to efficiently identify qualified candidates for their critical projects while providing workers with opportunities to advance their careers. The founding team includes professionals with extensive experience in construction staffing, software engineering, and global market expansion, positioning Buildforce to effectively address the challenges faced by contractors in scaling their workforce without increasing risk and overhead.
Saranas, Inc. is a medical device company based in Houston, Texas, focused on improving patient outcomes through the early detection of bleeding complications during vascular access procedures. Founded in 2011, Saranas has developed a patented bleeding monitoring system that utilizes a regional bioimpedance signal to assess a patient's bleeding status in real-time. This system allows physicians to promptly address bleeding issues, thereby reducing potential complications and associated healthcare costs. Saranas aims to enhance safety in interventional and surgical settings by providing innovative solutions that minimize risks during medical procedures.
Alleviant Medical, Inc., a medical device company, develops therapies for congestive heart failure. It offers a transcatheter device to treat congestive heart failure. The company's proprietary technology relieves heart failure symptoms, improves the quality of life, and reduces hospital admissions due to heart failure exacerbations. Alleviant Medical, Inc. was founded in 2017 and is headquartered in Austin, Texas.
BrainCheck, Inc. specializes in cognitive health solutions aimed at healthcare and athletic organizations in the United States. Founded in 2013 and based in Houston, Texas, the company offers BrainCheck, a mobile interactive screening tool available on iOS and Android devices. This tool enables users to monitor their cognitive health, particularly concerning issues like concussions and memory changes, by tracking performance over time and comparing results with general population data. The development of BrainCheck is grounded in two decades of research from the Eagleman Laboratory for Perception and Action at Baylor College of Medicine, led by Dr. David Eagleman. The platform encourages users to engage in meaningful discussions with their clinicians regarding their cognitive health, thereby facilitating informed decision-making. Through its innovative approach, BrainCheck aims to enhance understanding of brain function and empower individuals with actionable data.
BrainCheck, Inc. specializes in cognitive health solutions aimed at healthcare and athletic organizations in the United States. Founded in 2013 and based in Houston, Texas, the company offers BrainCheck, a mobile interactive screening tool available on iOS and Android devices. This tool enables users to monitor their cognitive health, particularly concerning issues like concussions and memory changes, by tracking performance over time and comparing results with general population data. The development of BrainCheck is grounded in two decades of research from the Eagleman Laboratory for Perception and Action at Baylor College of Medicine, led by Dr. David Eagleman. The platform encourages users to engage in meaningful discussions with their clinicians regarding their cognitive health, thereby facilitating informed decision-making. Through its innovative approach, BrainCheck aims to enhance understanding of brain function and empower individuals with actionable data.
Zdaly is the system of Predictive Intelligence that integrates internal data with the largest unified source of world trends and econometrics. Our technology maps billions of internal data points to external trends to discover key insights for optimizing global operations, supply chain, pricing, procurement and financial decisions.